Cambridge Investment Research Advisors’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $394K | Buy |
9,025
+11
| +0.1% | +$480 | ﹤0.01% | 2763 |
|
|
2025
Q1 | $247K | Hold |
9,014
| – | – | ﹤0.01% | 3039 |
|
|
2024
Q4 | $363K | Hold |
9,014
| – | – | ﹤0.01% | 2681 |
|
|
2024
Q3 | $427K | Sell |
9,014
-1,000
| -10% | -$47.4K | ﹤0.01% | 2534 |
|
|
2024
Q2 | $299K | Hold |
10,014
| – | – | ﹤0.01% | 2705 |
|
|
2024
Q1 | $403K | Buy |
10,014
+1,000
| +11% | +$40.2K | ﹤0.01% | 2463 |
|
|
2023
Q4 | $229K | Buy |
+9,014
| New | +$229K | ﹤0.01% | 2811 |
|
|
2023
Q3 | – | Sell |
-9,014
| Closed | -$207K | – | 3211 |
|
|
2023
Q2 | $207K | Hold |
9,014
| – | – | ﹤0.01% | 2844 |
|
|
2023
Q1 | $267K | Hold |
9,014
| – | – | ﹤0.01% | 2589 |
|
|
2022
Q4 | $225K | Buy |
+9,014
| New | +$225K | ﹤0.01% | 2657 |
|
|
2022
Q2 | – | Sell |
-9,014
| Closed | -$381K | – | 3149 |
|
|
2022
Q1 | $381K | Hold |
9,014
| – | – | ﹤0.01% | 2342 |
|
|
2021
Q4 | $572K | Hold |
9,014
| – | – | ﹤0.01% | 1994 |
|
|
2021
Q3 | $529K | Sell |
9,014
-100
| -1% | -$5.87K | ﹤0.01% | 2008 |
|
|
2021
Q2 | $442K | Buy |
9,114
+100
| +1% | +$4.85K | ﹤0.01% | 2147 |
|
|
2021
Q1 | $350K | Hold |
9,014
| – | – | ﹤0.01% | 2177 |
|
|
2020
Q4 | $559K | Buy |
+9,014
| New | +$559K | ﹤0.01% | 1699 |
|